Deliver high-quality ideation, framing & execution of strategic projects to evolve the Regulatory function, processes & partnering across international operations. Develop & sustain partnerships with key internal/external stakeholders and collaborate across geographies and functions on initiatives of broad reach and business impact.

Presenter at Novo Nordisk and Universities careers and attraction events (virtual and face-to-face) on the PhD to industry transition, the Novo Nordisk graduate programme, and careers within Regulatory Affairs as an international expat. Guest writer for promo articles, and collaborate with NN Employer Branding and Synapse student organisation.

Provide strategic direction and scientific guidance to 12 affiliates regulatory teams across our Business Area of 75 countries in Regulatory Affairs (RA), whilst working closely with RA & cross-functional colleagues across our area (Middle East, Africa, CIS), our Mother region, International Operations, and the Copenhagen & Bangalore HQs. Responsibilities vary from leading the development & implementation of strategic products submission & approval plans to secure earlier & optimal patient access, and ensuring Business Area functional governance and process support to help optimize the regulatory operating models and cross-functional alignment in terms of regulatory intelligence, life cycle management, labelling, policy follow-up and strategic health authorities’ engagements (often involving travel to affiliate offices and engaging with regulators and decision-makers at health authorities and MoHs).I also built my own immediate team, consisting of a Business Area Regulatory Coordinator whilst also hosting & managing Graduate Programme candidates on 8-month rotations from the Copenhagen HQ.

Member of cross-functional teams driving early development of innovative weight management compounds to treat patients who are overweight or living with obesity. I was the Regulatory support for 3 products and the responsible for 2 products in the pipeline, ranging from non-clinical and phase 1, 2, 3 clinical studies, and lead the planning and communication with the US FDA for an innovative pen-injector device to deliver one of the aforementioned products.

September 2017 - April 2018: Copenhagen, DK (Novo Nordisk HQ)I spent 8 months working in the life cycle management (LCM) clinical department for modern and human insulins. My role included reviewing/submitting pharmacovigilance documents (RMP, PSURs, DSURs), completing affiliate requests for documentation, driving a project to create a document package supporting the innovator status of a line of our modern insulin products to support colleagues in countries where guidelines defining originator/reference/innovator and biosimilar products are either lacking or unclear, & driving a labelling alignment project.May 2018 - December 2018: Dubai, UAE (Regional office)I was positioned in the Regional AAMEO (Africa, Asia, Middle East, and Oceania) Regulatory Affairs department. Alongside the senior RA manager, we were both responsible for 110 countries, driving operational and strategic projects across the entire region. These included:- Evaluation and optimisation of the current RA operating model- Implementation of strategic plans to improve various RA processes- Mapping of biosimilar guidelines, or the lack thereof, across the region in aid of plans for advocacy.- Working on cross-functional projects with stakeholders from marketing, market access and medical affairs.- Planning and rolling out workshops with affiliates and business areas.- Collecting affiliate RA-specific performance data in collaboration with an external organisation, and creating new data output for the organisation.January 2019 - September 2019: Copenhagen, DK (HQ)I then spent the final 8 months in the Regulatory Affairs Chemistry, Manufacturing and Control department for biopharmaceutical products, specifically working on LCM for NovoEight. Some of the tasks included assessing global regulatory impact of changes to various manufacturing processes, distributing NDA dossiers to follow-on countries, & compiling and submitting Type 1B and Type 2 variations to EMA.

To explore & establish internal (Novo Nordisk) & external partnerships to improve inter-cultural intelligence and inclusivity across EVP areas. How? By improving internal processes (onboarding & global mobility), widening the NovoNations membership network & closing sponsorship deals, raising awareness on local Danish processes and inter-cultural inclusivity needs and efforts in our professional & personal lives.

www.luhvdrinks.com/team-luhv/Head of the Science & Research team at a new health drinks start-up enterprise, LUHV Limited.Created 5 new drinks backed by nutritional research evidence, worked with specialist taste profilers, and provided nutritional, scientific and general advice to bring drinks to market. Further ranges I helped develop have since been created and are due to launch. I also filmed educational videos and wrote articles for the website, in addition to information tidbits supporting our drinks in drink and innovation competitions (which we have since won awards for).

Guy's and St Thomas' Charity Prize PhD Programme in Biomedical & Translational ScienceMy project centres on diabetes-induced mitochondrial dysfunction in Alzheimer's disease and how this mechanism may play a part in the link between these two prevalent diseases, using animal models and human patient samples.Transferable skills acquired:• Building relationships, leadership skills and self-management• Commercial awareness / Business experience• Knowledge of research• Communication skills and public engagement• Meeting deadlines and organisational skills • Data analysisFor further details on transferable skills acquired throughout my PhD, please contact me.

I worked for KCL as a consultant in my spare time during the latter half of my PhD. For one of the projects, I was hired by a new health drinks start-up enterprise as Head of the Science & Research team. I led the team to create 5 new drinks backed by nutritional research evidence, worked with specialist taste profilers, and provided nutritional and general advice to bring drinks to market. I have since conducted further research and created additional ranges, in addition to filming educational videos and writing articles.

This involves teaching and supervising undergraduate students who carry out short term projects in the lab, as well as invigilating exams.

1. Presenting research at national and European conferences. This entails explaining posters summarising my work at all levels of complexity to audiences and responding to questions. 2. Networking at conferences, instigating successful collaborations within the department, across Europe and USA.

Devised and delivered fun activities on nutrition and food security to the public at science festivals.

I write short articles on recent neuroscience-related and peer-reviewed studies for the online science community

I worked on the potential role of GM-CSF, a pro-inflammatory molecule, in spinal cord regeneration.

I performed a wide scope of behavioural tests on TDP-43 knockout mice.

I carried out my BSc final year project in Prof. Giles Hardingham's lab, specifically investigating the neuroprotective effects of various drugs against glutamate toxicity in primary cortical cultures. This resulted in a publication.